Laura A. Demopoulos

6.1k total citations · 1 hit paper
39 papers, 4.3k citations indexed

About

Laura A. Demopoulos is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Laura A. Demopoulos has authored 39 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cardiology and Cardiovascular Medicine, 19 papers in Surgery and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Laura A. Demopoulos's work include Acute Myocardial Infarction Research (21 papers), Coronary Interventions and Diagnostics (16 papers) and Cardiac Imaging and Diagnostics (10 papers). Laura A. Demopoulos is often cited by papers focused on Acute Myocardial Infarction Research (21 papers), Coronary Interventions and Diagnostics (16 papers) and Cardiac Imaging and Diagnostics (10 papers). Laura A. Demopoulos collaborates with scholars based in United States, Germany and Canada. Laura A. Demopoulos's co-authors include Peter M. DiBattiste, Christopher P. Cannon, Paul DeLucca, William S. Weintraub, Eugene Braunwald, Franz‐Josef Neumann, C. Michael Gibson, Debbie Robertson, Sabina A. Murphy and Nasser Lakkis and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Laura A. Demopoulos

39 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor Tirofiban

2001 1.4k citations Christopher P. Cannon, William S. Weintraub et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Laura A. Demopoulos

Since Specialization

Citations

This map shows the geographic impact of Laura A. Demopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura A. Demopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura A. Demopoulos more than expected).

Fields of papers citing papers by Laura A. Demopoulos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura A. Demopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura A. Demopoulos. The network helps show where Laura A. Demopoulos may publish in the future.

Co-authorship network of co-authors of Laura A. Demopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of Laura A. Demopoulos. A scholar is included among the top collaborators of Laura A. Demopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura A. Demopoulos. Laura A. Demopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effects of the Novel Long-Acting GLP-1 Agonist, Albiglutide, on Cardiac Function, Cardiac Metabolism, and Exercise Capacity in Patients With Chronic Heart Failure and Reduced Ejection Fraction 2016 ·JACC Heart Failure ·John J. Lepore, Eric J. Olson, Laura A. Demopoulos, (unknown), Zixing Fang, April Barbour, Michael J. Fossler, Víctor G. Dávila‐Román, Stuart D. Russell, Robert J. Gropler	108
2	Reduced Risk of Cytomegalovirus Infection in Solid Organ Transplant Recipients Treated With Sirolimus: A Pooled Analysis of Clinical Trials 2008 ·Transplantation Proceedings ·Laura A. Demopoulos, Martin S. Polinsky, (unknown), Daniel Mines, Manuel R. Blum, Maureen Caulfield, (unknown), (unknown), M. Harler, (unknown), Anurag K. Singh	60
3	Pericardial Effusion Coincident With Sirolimus Therapy: A Review of Wyeth's Safety Database 2008 ·Transplantation ·(unknown), (unknown), Laura A. Demopoulos, (unknown), Maureen Caulfield, Michael D. Blum, (unknown), (unknown), (unknown)	12
4	Early Invasive Strategy Improves Outcomes in Patients With Acute Coronary Syndrome With Previous Coronary Artery Bypass Graft Surgery 2006 ·Critical Pathways in Cardiology A Journal of Evidence-Based Medicine ·Aaron D. Kugelmass, Saihari Sadanandan, Nasser Lakkis, Peter M. DiBattiste, Debbie Robertson, Laura A. Demopoulos, C. Michael Gibson, William S. Weintraub, Sabina A. Murphy, Christopher P. Cannon	26
5	The JNC 7 Approach Compared to Conventional Treatment in Diabetic Patients With Hypertension: A Double‐Blind Trial of Initial Monotherapy vs. Combination Therapy 2004 ·Journal of Clinical Hypertension ·Jonathan C. Fox, (unknown), Santosh Sutradhar, Laura A. Demopoulos, Gilbert W. Gleim, Andrew Lewin, George L. Bakris	9
6	Association between duration of tirofiban therapy before percutaneous intervention and tissue level perfusion (a TACTICS-TIMI 18 substudy) 2004 ·The American Journal of Cardiology ·C. Michael Gibson, (unknown), Sabina A. Murphy, Peter M. DiBattiste, Laura A. Demopoulos, Christopher P. Cannon, Eugene Braunwald	15
7	Evaluation of B-type natriuretic peptide for risk assessment in unstable Angina/Non–ST-elevation myocardial infarction 2003 ·Journal of the American College of Cardiology ·David A. Morrow, James A. de Lemos, Marc S. Sabatine, Sabina A. Murphy, Laura A. Demopoulos, Peter M. DiBattiste, Carolyn H. McCabe, C. Michael Gibson, Christopher P. Cannon, Eugene Braunwald	318
8	Time for contrast material to traverse the epicardial artery and the myocardium in ST-Segment elevation acute myocardial infarction versus unstable angina pectoris/non–ST-elevation acute myocardial infarction 2003 ·The American Journal of Cardiology ·Graham C. Wong, Daniel R. Frisch, Sabina A. Murphy, Marc S. Sabatine, (unknown), David James, (unknown), Peter T. Katsiyiannis, Susan J. Marble, Peter M. DiBattiste, Laura A. Demopoulos, Steven G. Gourlay, Hal V. Barron, Christopher P. Cannon, C. Michael Gibson	5
9	Association of an activated clotting time ≤250 seconds with adverse event rates after percutaneous coronary intervention using tirofiban and heparin (a TACTICS-TIMI 18 substudy) 2003 ·The American Journal of Cardiology ·Duane S. Pinto, David Lorenz, Sabina A. Murphy, Susan J. Marble, Peter M. DiBattiste, Laura A. Demopoulos, Christopher P. Cannon, C. Michael Gibson	10
10	Angiographic variables predict increased riskfor adverse ischemic events after coronarystenting with glycoprotein IIb/IIIa inhibition 2003 ·Journal of the American College of Cardiology ·(unknown), Howard C. Herrmann, David J. Moliterno, James C. Blankenship, Laura A. Demopoulos, Peter M. DiBattiste, Stephen G. Ellis, Ziyad M.B. Ghazzal, Jack L. Martin, Jennifer White, Eric J. Topol	20
11	Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study 2002 ·The Lancet ·David J. Moliterno, Steven J. Yakubov, Peter M. DiBattiste, Howard C. Herrmann, Gregg W. Stone, Carlos Macaya, Franz‐Josef Neumann, Diego Ardissino, Jean‐Pierre Bassand, (unknown), Alan C. Yeung, Katherine Harris, Laura A. Demopoulos, Eric J. Topol	53
12	Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non–ST-elevation acute coronary syndromes 2002 ·Journal of the American College of Cardiology ·Neal S. Kleiman, Nasser Lakkis, Christopher P. Cannon, Sabina A. Murphy, Peter M. DiBattiste, Laura A. Demopoulos, William S. Weintraub, Eugene Braunwald	44
13	Elevated white blood cell count is associated with higher mortality in patients with acute coronary syndromes independent of other cardiac markers: a TACTICS - TIMI 18 Substudy 2002 ·Journal of the American College of Cardiology ·Marc S. Sabatine, David A. Morrow, Sabina A. Murphy, Laura A. Demopoulos, Peter M. DiBattiste, Carolyn H. McCabe, Christopher P. Cannon, Eugene Braunwald, Michael Gibson	1
14	Efficacy and safety of multivessel percutaneous revascularization and tirofiban therapy in patients with acute coronary syndromes 2002 ·The American Journal of Cardiology ·Sorin J. Brener, Sabina A. Murphy, C. Michael Gibson, Peter M. DiBattiste, Laura A. Demopoulos, Christopher P. Cannon	42
15	Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes 2002 ·Journal of the American College of Cardiology ·Marc S. Sabatine, David A. Morrow, Christopher P. Cannon, Sabina A. Murphy, Laura A. Demopoulos, Peter M. DiBattiste, Carolyn H. McCabe, Eugene Braunwald, C. Michael Gibson	221
16	Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor Tirofiban breakdown → 2001 ·New England Journal of Medicine ·Christopher P. Cannon, William S. Weintraub, Laura A. Demopoulos, Ralph Vicari, Martin J. Frey, Nasser Lakkis, Franz‐Josef Neumann, Debbie Robertson, Paul DeLucca, Peter M. DiBattiste, C. Michael Gibson, Eugene Braunwald	1390
17	Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina with Aggrastat® [tirofiban] and Determine Cost of Therapy with Invasive or Conservative Strategy)–TIMI 18 trial 1999 ·The American Journal of Cardiology ·William S Weintraub, Steven D. Culler, Andrzej S. Kosinski, Edmund R. Becker, Elizabeth M. Mahoney, Joy Burnette, John A. Spertus, David Feeny, David J. Cohen, Harlan M. Krumholz, Stephen G. Ellis, Laura A. Demopoulos, Deborah Robertson, Stephen J. Boccuzzi, Eliav Barr, Christopher P. Cannon	27
18	Exercise Training in Patients With Severe Congestive Heart Failure: Enhancing Peak Aerobic Capacity While Minimizing the Increase in Ventricular Wall Stress 1997 ·Journal of the American College of Cardiology ·Laura A. Demopoulos, Rachel Bijou, Icilma Fergus, Margaret T. Jones, Joel A. Strom, Thierry H. LeJemtel	114
19	Peripheral factors in the management of congestive heart failure 1994 ·Cardiovascular Drugs and Therapy ·Laura A. Demopoulos, Thierry H. LeJemtel	7
20	Pitfalls in the Diagnosis of Thoracic Aortic Aneurysm by Transesophageal Echocardiography 1990 ·Journal of the American Society of Echocardiography ·Itzhak Kronzon, Laura A. Demopoulos, (unknown), Peter F. Pasternack, Dorothy I. McCauley, Robin S. Freedberg	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact